John L. Leguyader

Array ( [id] => 4002829 [patent_doc_number] => 05858988 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Poly-substituted-phenyl-oligoribo nucleotides having enhanced stability and membrane permeability and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/604871 [patent_app_country] => US [patent_app_date] => 1996-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 25 [patent_no_of_words] => 13337 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858988.pdf [firstpage_image] =>[orig_patent_app_number] => 604871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4029283 [patent_doc_number] => 05855881 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Mammalian alcohol dehydrogenase and aldehyde dehydrogenase production in plants' [patent_app_type] => 1 [patent_app_number] => 8/565447 [patent_app_country] => US [patent_app_date] => 1996-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 19994 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/855/05855881.pdf [firstpage_image] =>[orig_patent_app_number] => 565447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4198828 [patent_doc_number] => 06013639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'G cap-stabilized oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/594452 [patent_app_country] => US [patent_app_date] => 1996-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10339 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013639.pdf [firstpage_image] =>[orig_patent_app_number] => 594452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3925500 [patent_doc_number] => 05877021 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'B7-1 targeted ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/585684 [patent_app_country] => US [patent_app_date] => 1996-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 113888 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877021.pdf [firstpage_image] =>[orig_patent_app_number] => 585684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3952115 [patent_doc_number] => 05955599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages' [patent_app_type] => 1 [patent_app_number] => 8/570390 [patent_app_country] => US [patent_app_date] => 1995-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6889 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955599.pdf [firstpage_image] =>[orig_patent_app_number] => 570390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686416 [patent_doc_number] => 05695995 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Neurogenic differentiation (neurod) genes' [patent_app_type] => 1 [patent_app_number] => 8/552142 [patent_app_country] => US [patent_app_date] => 1995-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17176 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695995.pdf [firstpage_image] =>[orig_patent_app_number] => 552142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890412 [patent_doc_number] => 05834440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Ribozyme therapy for the inhibition of restenosis' [patent_app_type] => 1 [patent_app_number] => 8/527060 [patent_app_country] => US [patent_app_date] => 1995-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 7388 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834440.pdf [firstpage_image] =>[orig_patent_app_number] => 527060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589244 [patent_doc_number] => 06482803 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A' [patent_app_type] => B1 [patent_app_number] => 08/523030 [patent_app_country] => US [patent_app_date] => 1995-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 22987 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482803.pdf [firstpage_image] =>[orig_patent_app_number] => 08523030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3714176 [patent_doc_number] => 05616466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Ribozyme-mediated inhibition of bovine leukemia virus' [patent_app_type] => 1 [patent_app_number] => 8/520226 [patent_app_country] => US [patent_app_date] => 1995-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6366 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616466.pdf [firstpage_image] =>[orig_patent_app_number] => 520226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241441 [patent_doc_number] => 06080851 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Ribozymes with linked anchor sequences' [patent_app_type] => 1 [patent_app_number] => 8/448446 [patent_app_country] => US [patent_app_date] => 1995-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 7 [patent_no_of_words] => 14158 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080851.pdf [firstpage_image] =>[orig_patent_app_number] => 448446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045913 [patent_doc_number] => 05869339 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'HIV targeted hairpin ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/478608 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 80 [patent_no_of_words] => 32310 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869339.pdf [firstpage_image] =>[orig_patent_app_number] => 478608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034123 [patent_doc_number] => 05856188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Hairpin ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/485689 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 78 [patent_no_of_words] => 32329 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 384 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856188.pdf [firstpage_image] =>[orig_patent_app_number] => 485689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932272 [patent_doc_number] => 05928947 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Mammalian multipotent neural stem cells' [patent_app_type] => 1 [patent_app_number] => 8/483142 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 20 [patent_no_of_words] => 18572 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928947.pdf [firstpage_image] =>[orig_patent_app_number] => 483142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3704595 [patent_doc_number] => 05654177 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Production of human somatomedin C' [patent_app_type] => 1 [patent_app_number] => 8/479006 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7095 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654177.pdf [firstpage_image] =>[orig_patent_app_number] => 479006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4115942 [patent_doc_number] => 06071730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Cell ablation using trans-splicing ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/475610 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 18 [patent_no_of_words] => 17886 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071730.pdf [firstpage_image] =>[orig_patent_app_number] => 475610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766723 [patent_doc_number] => 05849482 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Crosslinking oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/485611 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19952 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849482.pdf [firstpage_image] =>[orig_patent_app_number] => 485611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4022941 [patent_doc_number] => 05882907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Cell ablation using trans-splicing ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/482663 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 16600 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882907.pdf [firstpage_image] =>[orig_patent_app_number] => 482663 [rel_patent_id] =>[rel_patent_doc_number] =>)